Department of Obstetrics and Gynecology, EOC, Beata Vergine Hospital, 6850 Mendrisio, Switzerland.
Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland.
Medicina (Kaunas). 2022 Oct 8;58(10):1412. doi: 10.3390/medicina58101412.
: Stress urinary incontinence (SUI) is the most common type of urinary incontinence, affecting approximately 46% of adult women. After failure of conservative treatment, the mid-urethral sling (MUS) is considered the most effective and safe surgical procedure for SUI. In 2012, Waltregny et al. introduced a new trans-obturator tension-free vaginal tape (TVT) procedure, named TVT-abbrevo (TVT-A). The aim of the present study is to evaluate the efficacy and safety of the TVT-A procedure in women with pure SUI at 5-year follow-up. : All women who complained of pure SUI symptoms with concomitant urodynamic stress incontinence (USI) were prospectively enrolled and treated with the TVT-A procedure. Postoperative subjective outcome measures included: International Consultation on Incontinence Questionnaire-Short Form (ICI-Q SF), Patient Global Impression of Improvement (PGI-I) scale, and patient degree of satisfaction scale. A PGI-I score ≤ 2 and a patient-satisfaction score ≥8 were used to define subjective success. Objective success was defined as the absence of urine leakage during a cough stress test. Adverse events were collected according to the Clavien-Dindo classification during follow-up. : Univariable analysis was used to investigate outcomes. Fifty women who met the inclusion criteria underwent TVT-A implantation. At 5 years after TVT-A implantation, 38 out of 45 (84.4%) patients were subjectively cured ( for trend 0.05), and 40 out of 45 (88.9%) patients were objectively cured ( for trend 0.04). A significant trend of de novo OAB symptoms was reported (22.2% [10/45]) at the 5-year follow-up. No serious early or late complications such as urethral/bladder injury, persistent groin-thigh pain, and sexual dysfunction that required mesh removal were detected. The univariate analysis did not reveal any risk factors (i.e., age, body mass index (BMI), menopause, obstetric factors, and preoperative ICIQ- SF questionnaire) statistically associated with failure of the TVT-A procedure. In conclusion, the 5-year follow-up results of this study demonstrated that TVT-A is a safe and effective option for treatment of SUI with a very low rate of post-operative groin-thigh pain.
压力性尿失禁(SUI)是最常见的尿失禁类型,约影响 46%的成年女性。在保守治疗失败后,尿道中段吊带(MUS)被认为是治疗 SUI 最有效和安全的手术方法。2012 年,Waltregny 等人引入了一种新的经闭孔无张力阴道吊带(TVT)手术,命名为 TVT-abbrevo(TVT-A)。本研究旨在评估 TVT-A 手术治疗单纯性压力性尿失禁(SUI)女性的 5 年随访疗效和安全性。
所有因单纯性 SUI 症状合并压力性尿失禁(USI)而抱怨的女性均前瞻性纳入并接受 TVT-A 手术治疗。术后主观疗效评估包括:国际尿失禁咨询委员会问卷-短表(ICI-Q SF)、患者总体印象改善(PGI-I)量表和患者满意度评分。PGI-I 评分≤2 和患者满意度评分≥8 定义为主观成功。客观成功定义为咳嗽应激试验时无尿漏。在随访期间,根据 Clavien-Dindo 分类收集不良事件。
采用单变量分析评估结局。符合纳入标准的 50 例女性接受了 TVT-A 植入术。TVT-A 植入后 5 年,45 例中有 38 例(84.4%)患者主观治愈( for trend 0.05),45 例中有 40 例(88.9%)患者客观治愈( for trend 0.04)。5 年随访时报告新出现 OAB 症状的趋势显著(22.2%[10/45])。未发现严重的早期或晚期并发症,如尿道/膀胱损伤、持续性腹股沟-大腿疼痛和需要去除网片的性功能障碍。单变量分析未发现任何与 TVT-A 手术失败相关的危险因素(即年龄、体重指数(BMI)、绝经、产科因素和术前 ICIQ-SF 问卷)。
总之,本研究的 5 年随访结果表明,TVT-A 是治疗 SUI 的一种安全有效的选择,术后腹股沟-大腿疼痛发生率非常低。